Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism

After suffering pulmonary embolism (PE), doctors are confronted with various consequences of the disease, from asymptomatic residual pulmonary thrombosis to the formation of chronic thromboembolic pulmonary hypertension (CTEPH). There is also a subgroup of patients who have undergone pulmonary embol...

Full description

Bibliographic Details
Main Authors: A. A. Klimenko, N. A. Demidova, N. A. Shostak, M. O. Anischenko
Format: Article
Language:English
Published: Столичная издательская компания 2020-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/2360
_version_ 1826949570902360064
author A. A. Klimenko
N. A. Demidova
N. A. Shostak
M. O. Anischenko
author_facet A. A. Klimenko
N. A. Demidova
N. A. Shostak
M. O. Anischenko
author_sort A. A. Klimenko
collection DOAJ
description After suffering pulmonary embolism (PE), doctors are confronted with various consequences of the disease, from asymptomatic residual pulmonary thrombosis to the formation of chronic thromboembolic pulmonary hypertension (CTEPH). There is also a subgroup of patients who have undergone pulmonary embolism, who experience shortness of breath during physical exertion, absent before pulmonary embolism, or shortened dyspnea preceding PE, combined with residual thrombosis of pulmonary artery (PA) and normal average pressure in PA at rest during catheterization of the right heart (CRH). This condition is defined as chronic thromboembolic pulmonary disease or post thromboembolic syndrome. Pathogenetic aspects of this condition are not fully investigated. It is important to predict the development of postembolic syndrome and to develop algorithms for the diagnosis, treatment and rehabilitation of patients with symptoms and residual pulmonary thrombosis. In case of the development of pulmonary vasculopathy in some patients who have undergone pulmonary embolism, a severe life-threatening condition forms - CTEPH, characterized by an increase in pressure in the pulmonary artery, right heart failure due to the presence of organized blood clots that have entered the pulmonary vascular bed during PE. The volume of thrombotic masses does not always correlate with clinical symptoms, which indicates the importance of microvascular remodeling. If CTEPH is suspected, a diagnostic algorithm is required, including ventilation-perfusion scintigraphy, CT angiopulmonography and catheterization of the right heart. Treating a patient with CTEPH is a difficult task fora doctor. The timely referral of the patient to the center where they are involved in treatment, including surgery and CTEPH is extremely important. Timely performed thrombendarterectomy in some cases allows to completely cure the patient. In the case of inoperable CTEPH or residual pulmonary hypertension after thrombendarterectomy, balloon angioplasty of the PA is used as well as drug treatment with specific drugs that reduce the pressure in the PA (riociguat), endothelin receptor antagonists (bosentan, macitentan), prostanoids (inhalant illoprost) phosphodiesterase-5 inhibitor and combined therapy. In this article we considered some consequences directly related to PE: asymptomatic residual pulmonary thrombosis, chronic thromboembolic pulmonary disease, chronic thromboembolic pulmonary hypertension.
first_indexed 2024-03-08T14:00:54Z
format Article
id doaj.art-37ae0ea1e80242c7979c07a54aa2300c
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2025-02-17T22:16:15Z
publishDate 2020-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-37ae0ea1e80242c7979c07a54aa2300c2024-12-04T11:48:19ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532020-12-011661002100810.20996/1819-6446-2020-12-091831Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary EmbolismA. A. Klimenko0N. A. Demidova1N. A. Shostak2M. O. Anischenko3Pirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityAfter suffering pulmonary embolism (PE), doctors are confronted with various consequences of the disease, from asymptomatic residual pulmonary thrombosis to the formation of chronic thromboembolic pulmonary hypertension (CTEPH). There is also a subgroup of patients who have undergone pulmonary embolism, who experience shortness of breath during physical exertion, absent before pulmonary embolism, or shortened dyspnea preceding PE, combined with residual thrombosis of pulmonary artery (PA) and normal average pressure in PA at rest during catheterization of the right heart (CRH). This condition is defined as chronic thromboembolic pulmonary disease or post thromboembolic syndrome. Pathogenetic aspects of this condition are not fully investigated. It is important to predict the development of postembolic syndrome and to develop algorithms for the diagnosis, treatment and rehabilitation of patients with symptoms and residual pulmonary thrombosis. In case of the development of pulmonary vasculopathy in some patients who have undergone pulmonary embolism, a severe life-threatening condition forms - CTEPH, characterized by an increase in pressure in the pulmonary artery, right heart failure due to the presence of organized blood clots that have entered the pulmonary vascular bed during PE. The volume of thrombotic masses does not always correlate with clinical symptoms, which indicates the importance of microvascular remodeling. If CTEPH is suspected, a diagnostic algorithm is required, including ventilation-perfusion scintigraphy, CT angiopulmonography and catheterization of the right heart. Treating a patient with CTEPH is a difficult task fora doctor. The timely referral of the patient to the center where they are involved in treatment, including surgery and CTEPH is extremely important. Timely performed thrombendarterectomy in some cases allows to completely cure the patient. In the case of inoperable CTEPH or residual pulmonary hypertension after thrombendarterectomy, balloon angioplasty of the PA is used as well as drug treatment with specific drugs that reduce the pressure in the PA (riociguat), endothelin receptor antagonists (bosentan, macitentan), prostanoids (inhalant illoprost) phosphodiesterase-5 inhibitor and combined therapy. In this article we considered some consequences directly related to PE: asymptomatic residual pulmonary thrombosis, chronic thromboembolic pulmonary disease, chronic thromboembolic pulmonary hypertension.https://www.rpcardio.online/jour/article/view/2360acute pulmonary embolismpulmonary embolismchronic thromboembolic pulmonary hypertensionpost-thromboembolic syndromechronic thromboembolic pulmonary diseaseresidual pulmonary thrombosiscardiorespiratory testrehabilitation
spellingShingle A. A. Klimenko
N. A. Demidova
N. A. Shostak
M. O. Anischenko
Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism
Рациональная фармакотерапия в кардиологии
acute pulmonary embolism
pulmonary embolism
chronic thromboembolic pulmonary hypertension
post-thromboembolic syndrome
chronic thromboembolic pulmonary disease
residual pulmonary thrombosis
cardiorespiratory test
rehabilitation
title Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism
title_full Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism
title_fullStr Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism
title_full_unstemmed Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism
title_short Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism
title_sort thrombotic lesion of the pulmonary vessels in patients with pulmonary embolism
topic acute pulmonary embolism
pulmonary embolism
chronic thromboembolic pulmonary hypertension
post-thromboembolic syndrome
chronic thromboembolic pulmonary disease
residual pulmonary thrombosis
cardiorespiratory test
rehabilitation
url https://www.rpcardio.online/jour/article/view/2360
work_keys_str_mv AT aaklimenko thromboticlesionofthepulmonaryvesselsinpatientswithpulmonaryembolism
AT nademidova thromboticlesionofthepulmonaryvesselsinpatientswithpulmonaryembolism
AT nashostak thromboticlesionofthepulmonaryvesselsinpatientswithpulmonaryembolism
AT moanischenko thromboticlesionofthepulmonaryvesselsinpatientswithpulmonaryembolism